| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $48880 | $47875 | $46568 | $44736 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $2753086 | $2699258 | $2700042 | $2591499 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $151523 | $49626 | $152711 | $41859 |
| Long term debt | $131251 | $211908 | $117638 | $196711 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $2628125 | $2577076 | $2575031 | $2467757 |
| Shareholders' equity | ||||
| Retained earnings | $9366 | $93340 | $3103 | $92110 |
| Other shareholder equity | -$3245 | $9683 | -$3057 | $10759 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $44736 | $38468 | $34508 | $32895 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $2591499 | $2666376 | $2634444 | $2488491 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $41859 | $13928 | $9526 | $8372 |
| Long term debt | $196711 | $176205 | $173525 | $151368 |
| Total noncurrent liabilities | $151368 | |||
| Total debt | ||||
| Total liabilities | $2467757 | $2544584 | $2516558 | $2375692 |
| Shareholders' equity | ||||
| Retained earnings | $92110 | $10196 | $82110 | $76294 |
| Other shareholder equity | $10759 | -$3553 | $6440 | $7303 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12165 | |||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $1051 | |||
| Interest expense | ||||
| Net income | ||||
| Net income | $2868 | |||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $70226 | |||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $3266 | |||
| Interest expense | ||||
| Net income | ||||
| Net income | $10298 | |||
| Income (for common shares) | ||||
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $1035 | $7304 | $8681 | -$2163 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$7528 | -$4676 | -$3868 | $9250 |
| Effect of exchange rate | -$2596 | -$3506 | -$4386 | $1030 |
| Change in cash and equivalents | -$102247 | -$35119 | -$22396 | -$44720 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $7304 | -$2163 | -$1182 | -$851 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$4676 | $9250 | $14516 | $18524 |
| Effect of exchange rate | -$3506 | $1030 | $107 | -$2614 |
| Change in cash and equivalents | -$35119 | -$44720 | $55817 | $154383 |
| Market cap | $97.04B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.13B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 3.32% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |